Remote Fetal Monitoring in High Risk Pregnancies
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Beth Israel Deaconess Medical Center
- Study ID
- NCT06822439
- Status
- Recruiting
Conditions
- Diabetes
- High Risk Pregnancy
- Hypertension
- Remote Patient Monitoring
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Fetal ECG monitoring — DEVICEPatients will wear a fetal ECG monitor which they will place on their abdomen
Study Details
Antenatal nonstress tests (NSTs) are performed to assess fetal health and are used as a cost-effective test that can be widely administered. However, an NST is operator-dependent due to the nature of Doppler ultrasound and is primarily performed in a clinic and hospital setting. The ability to conduct a clinically valuable test at home would address access to care issues faced by numerous women in the United States and reduce the workload on healthcare clinicians facing a shortage of human resources. This pilot study aims to assess the feasibility and acceptability of home NST monitoring in order to determine whether femomTM could be utilized as an adjunct to routine prenatal care. Patients with high risk pregnancies who are recommended to undergo at least once weekly at 32 weeks testing by the obstetrician will be recruited for participation in this study. Participants will be asked to perform three 30 minute monitoring sessions weekly starting at 32 weeks for 6 weeks.
Key Dates
- Start date
- May 1, 2025
- Status verified
- Mar 2026
- Primary completion
- Dec 1, 2026
- Completion
- Jan 1, 2027
Study Design
- Enrollment
- 50 participants (estimated)
Arms
- Arm: Remote MonitoringA cohort of patients with high risk pregnancies who will wear a remote monitoring device
Primary Outcome Measure
Percent of sessions completed [ Time Frame: 6 weeks ]
Central Contacts
- Ethan Litman, MD, MS617-677-3000
- Chloe Zera, MD, MPH617-667-3000
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02115 | Chloe Zera, MD, MPH (PRINCIPAL_INVESTIGATOR) Ethan Litman, MD,MS (SUB_INVESTIGATOR) |
Find similar trials in Boston, MA
Related Studies
- Imaging Histone Deacetylase in the HeartRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- The T1D Exchange RegistryRecruiting · T1D Exchange, United States · Boston, Massachusetts